The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A preclinical study of tumor-infiltrating lymphocytes in NSCLC.
 
Lorenzo Federico
No Relationships to Disclose
 
Cara L. Haymaker
Research Funding - Idera; Nektar
 
Marie-Andree Forget
No Relationships to Disclose
 
Andrea Ravelli
No Relationships to Disclose
 
Ankit Bhatta
No Relationships to Disclose
 
Tatiana Karpinets
No Relationships to Disclose
 
Ran Zhang
No Relationships to Disclose
 
Annikka Weissferdt
No Relationships to Disclose
 
Bingliang Fang
No Relationships to Disclose
 
Jianjun Zhang
No Relationships to Disclose
 
Tina Cascone
No Relationships to Disclose
 
Ara A. Vaporciyan
No Relationships to Disclose
 
Andrew Futreal
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - Ariad; AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; HTG Molecular Diagnostics; Lilly; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Research Funding - Adaptimmune; EMD Serono; Genentech; HTG Molecular Diagnostics; MedImmune; Merck; Myriad Genetics; OncoPlex Diagnostics; Pfizer; Silicon Biosytems
 
Boris Sepesi
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Don Lynn Gibbons
No Relationships to Disclose
 
Chantale Bernatchez
Employment - Lexicon (I)
Stock and Other Ownership Interests - Lexicon (I)
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Idera; Nektar
Patents, Royalties, Other Intellectual Property - Patent pending on BTLA as a marker for better CD8 T cells for adoptive immunotherapy